Development of a physiologically based pharmacokinetic model of actinomycin D in children with cancer

Characterisation of the Clinical Pharmacokinetics of Actinomycin D and the Influence of ABCB1 Pharmacogenetic Variation on Actinomycin D Disposition in Children with Cancer

(2014) Christopher R. Hill et al.   CLINICAL PHARMACOKINETICS

A Mechanistic Framework for In Vitro–In Vivo Extrapolation of Liver Membrane Transporters: Prediction of Drug–Drug Interaction Between Rosuvastatin and Cyclosporine

(2013) M. Jamei et al.   CLINICAL PHARMACOKINETICS

Dose Selection Based on Physiologically Based Pharmacokinetic (PBPK) Approaches

(2012) Hannah M. Jones et al.   AAPS Journal

Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivo

(2012) Christopher R. Hill et al.   BIOCHEMICAL PHARMACOLOGY

A physiologically based pharmacokinetic (PBPK) approach to evaluate pharmacokinetics in patients with cancer

(2012) Sravanthi Cheeti et al.   BIOPHARMACEUTICS & DRUG DISPOSITION

Guide to Receptors and Channels (GRAC), 5th edition

(2011) SPH Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Physiologically based pharmacokinetic modelling of high- and low-dose etoposide: from adults to children

(2011) Gisela Kersting et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

A Semi-Mechanistic Model to Predict the Effects of Liver Cirrhosis on Drug Clearance

(2010) Trevor N. Johnson et al.   CLINICAL PHARMACOKINETICS

Dactinomycin and vincristine toxicity in the treatment of childhood cancer: A retrospective study from the Children's Oncology Group

(2010) Bryan Langholz et al.   PEDIATRIC BLOOD & CANCER

Population Pharmacokinetic Investigation of Actinomycin-D in Children and Young Adults

(2007) Joh T. Mondick et al.   JOURNAL OF CLINICAL PHARMACOLOGY